Wordt geladen...
Eltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report
BACKGROUND: Immune thrombocytopenic purpura (ITP) is a rare autoimmune disorder that involves platelet destruction in the spleen. Eltrombopag (Promacta®), a thrombopoietin agonist, has been used in non-pregnant patients to manage ITP, but few cases of its use in pregnancy have been reported. CASE PR...
Bewaard in:
| Gepubliceerd in: | Case Rep Womens Health |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7788087/ https://ncbi.nlm.nih.gov/pubmed/33437657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crwh.2020.e00281 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|